{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:54:38Z","timestamp":1789203278930,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":112,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005583.pub2","type":"reference-entry","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T01:05:18Z","timestamp":1437527118000},"source":"Crossref","is-referenced-by-count":37,"title":["<i>Helicobacter pylori<\/i>eradication for the prevention of gastric neoplasia"],"prefix":"10.1002","author":[{"given":"Alexander C","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"issue":"23","key":"10.1002\/14651858.CD005583.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD005583.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jnci\/93.7.559-a","article-title":"Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"93","author":"Correa","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"10.1002\/14651858.CD005583.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2005.072009","article-title":"Long term follow up of patients treated for Helicobacter pylori infection","volume":"54","author":"Mera","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1002\/14651858.CD005583.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1111\/j.1572-0241.2001.05326.x","article-title":"Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection","volume":"96","author":"Ruiz","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD005583.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2003.034629","article-title":"Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2000.8550","article-title":"Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study","volume":"119","author":"Sung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB7|cit7","series-title":"Gastroenterology","first-page":"A170. Abstract","article-title":"Does eradication of H. pylori prevent deterioration of gastric atrophy and intestinal metaplasia? A 5-year follow-up","author":"Sung","year":"2002"},{"key":"10.1002\/14651858.CD005583.pub2-BIB9|cit8","series-title":"Gastroenterology","first-page":"A233. Abstract","article-title":"Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China","author":"Zhou","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB8|cit9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3760\/cma.j.issn.0366-6999.20121090","article-title":"A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication","volume":"116","author":"Zhou","year":"2003","journal-title":"Chinese Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB10|cit10","first-page":"324","article-title":"Eight-year follow-up study on prevalence of gastric cancer and the histological changes of gastric mucosa after H.pylori eradication","volume":"25","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Digestion"},{"key":"10.1002\/14651858.CD005583.pub2-BIB11|cit11","unstructured":"Zhou LY Lin SR Ding SG Huang SB Guo CJ Zhang L Eight-year follow-up study on the morbidity of gastric cancer and the pathological changes of gastric mucosa after H.pylori eradication www.paper.edu.cn\/scholar\/downpaper\/zhouliya-3"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1443-9573.2005.00204.x","article-title":"The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area","volume":"6","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Digestive Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1443-9573.2003.00104.x","article-title":"Five-year follow-up study after Helicobacter pylori eradication: Reinfection and peptic ulcer status","volume":"4","author":"Zhou","year":"2003","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD005583.pub2-BIB14|cit14","doi-asserted-by":"crossref","unstructured":"Zhou LY Sung JJ Lin SR Jin Z Ding SG Huang XB Changes of gastric mucosa histopathology after Helicobacterpylori eradication Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine] 2003 162 4","DOI":"10.1046\/j.1443-9573.2003.00104.x"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB16|cit15","first-page":"50","article-title":"Present state of Japanese intervention trial of H. pylori","volume":"61","author":"Saito","year":"2003","journal-title":"Nihon Rinsho"},{"key":"10.1002\/14651858.CD005583.pub2-BIB15|cit16","series-title":"Gastroenterology","first-page":"A4. Abstract 23","article-title":"Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial (JITHP-Study). A randomized multi-center trial","author":"Saito","year":"2005"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005583.pub2-BIB18|cit18","series-title":"Gastroenterology","first-page":"A588. Abstract","article-title":"Eradication of Helicobacter pylori infection significantly slows down the progression of precancerous lesions in high risk populations: a 5 year prospective randomized study","author":"Wong","year":"2002"},{"issue":"28","key":"10.1002\/14651858.CD005583.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3748\/wjg.14.4535","article-title":"Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention","volume":"14","author":"Feng","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB21|cit20","series-title":"Journal of Gastroenterology and Hepatology","first-page":"5-6. Abstract U","article-title":"Eradication of Helicobacter pylori for prevention of gastric cancer","author":"Wong","year":"2012"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB20|cit21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","article-title":"Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD005583.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0197-2456(98)00016-6","article-title":"Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data","volume":"19","author":"Gail","year":"1998","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005583.pub2-BIB23|cit23","first-page":"S61","article-title":"Fifteen-year effects of Helicobacter pylori treatment on gastric cancer incidence and mortality among participants with different baseline gastric lesions and ages","volume":"177 (Suppl 11)","author":"Li","year":"2013","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djs003","article-title":"Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality","volume":"104","author":"Ma","year":"2012","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/jn.108.091389","article-title":"Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population","volume":"139","author":"Wang","year":"2009","journal-title":"Journal of Nutrition"},{"issue":"14","key":"10.1002\/14651858.CD005583.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/djj264","article-title":"Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions","volume":"98","author":"You","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00008469-200106000-00009","article-title":"An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity","volume":"10","author":"You","year":"2001","journal-title":"European Journal of Cancer Prevention"},{"issue":"4","key":"10.1002\/14651858.CD005583.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/ajcn\/84.4.912","article-title":"A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins","volume":"86","author":"Zhang","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB29|cit29","first-page":"338","article-title":"A randomized multi-intervention trial to inhibit gastric cancer in Shandong (progress report)","volume":"25","author":"Zhang","year":"1998","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cgh.2013.09.057","article-title":"Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma","volume":"12","author":"Choi","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1365-2036.2001.00998.x","article-title":"Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer","volume":"15","author":"Fischbach","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1523-5378.2009.00667.x","article-title":"A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country","volume":"14","author":"Fischbach","year":"2009","journal-title":"Helicobacter"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1053\/j.gastro.2005.09.016","article-title":"A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial","volume":"129","author":"Ford","year":"2005","journal-title":"Gastroenterology"},{"issue":"9636","key":"10.1002\/14651858.CD005583.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1572-0241.2002.05571.x","article-title":"A pilot study to evaluate stomach cancer risk reduction by Helicobacter pylori eradication","volume":"97","author":"Hamajima","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"7453","key":"10.1002\/14651858.CD005583.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.38082.626725.EE","article-title":"Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project","volume":"328","author":"Harvey","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005583.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1572-0241.2006.01109.x","article-title":"Helicobacter pylori infection and the risk of gastric malignancy","volume":"102","author":"Hsu","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB38|cit38","series-title":"Gut","first-page":"A292","article-title":"Histopathology of the stomach mucosa after treatment for Helicobacter pylori: A multi-centric study","author":"Imanzadeh","year":"2004"},{"key":"10.1002\/14651858.CD005583.pub2-BIB39|cit39","series-title":"Gut","first-page":"A148","article-title":"Risk of precancerous pathologic changes in the stomach after appropriate eradication of Helicobacter pylori: A multi-centric study from a developing country","author":"Juibari","year":"2003"},{"issue":"20","key":"10.1002\/14651858.CD005583.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jnci\/djj393","article-title":"Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity","volume":"98","author":"Kamangar","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005583.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2036.2006.00046.x","article-title":"H.pylori eradication prevents the development of gastric cancer- results of a long-term retrospective study in Japan","volume":"24","author":"Kato","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e318046eac3","article-title":"Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow up","volume":"42","author":"Kim","year":"2008","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"7535","key":"10.1002\/14651858.CD005583.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.38702.662546.55","article-title":"Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial","volume":"332","author":"Lane","year":"2006","journal-title":"BMJ"},{"issue":"34","key":"10.1002\/14651858.CD005583.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.3748\/wjg.15.4290","article-title":"Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?","volume":"15","author":"Mabe","year":"2009","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2036.2002.01204.x","article-title":"The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial","volume":"16","author":"Mason","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3748\/wjg.v7.i2.243","article-title":"Helicobacter pylori and gastric cancer: current status of the Austrian Czech German gastric cancer prevention trial (PRISMA Study)","volume":"7","author":"Miehlke","year":"2001","journal-title":"World Journal of Gastroenterology"},{"issue":"9213","key":"10.1002\/14651858.CD005583.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","article-title":"Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group","volume":"355","author":"Moayyedi","year":"2000","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mcg.0000248006.80699.7f","article-title":"The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer","volume":"42","author":"Ogura","year":"2008","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-134-5-200103060-00010","article-title":"Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated","volume":"134","author":"Ohkusa","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1572-0241.2005.41384.x","article-title":"The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease","volume":"100","author":"Take","year":"2005","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD005583.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00535-006-1924-9","article-title":"Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases","volume":"42","author":"Take","year":"2007","journal-title":"Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD005583.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2007.03268.x","article-title":"Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type","volume":"25","author":"Takenaka","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD005583.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005583.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2302\/kjm.51.supplement2_63","article-title":"H. pylori infection and the development of gastric cancer","volume":"51","author":"Uemura","year":"2002","journal-title":"Keio Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0016-5085(03)00897-7","article-title":"Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population","volume":"125","author":"Wildner-Christensen","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD005583.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/ijc.24591","article-title":"Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels","volume":"125","author":"Yanaoka","year":"2009","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"8","author":"Akl","year":"2013","journal-title":"PLoS One"},{"issue":"7924","key":"10.1002\/14651858.CD005583.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(75)90498-5","article-title":"A model for gastric cancer epidemiology","volume":"2","author":"Correa","year":"1975","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD005583.pub2-BIB59|cit59","first-page":"437","article-title":"The gastric precancerous process","volume":"2","author":"Correa","year":"1983","journal-title":"Cancer Surveys"},{"issue":"7","key":"10.1002\/14651858.CD005583.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jnci\/93.7.559-a","article-title":"Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"93","author":"Correa","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.gassur.2004.12.002","article-title":"Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution","volume":"9","author":"Cunningham","year":"2005","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"12","key":"10.1002\/14651858.CD005583.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00268-006-0179-1","article-title":"Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary?","volume":"30","author":"Degiuli","year":"2006","journal-title":"World Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"28","key":"10.1002\/14651858.CD005583.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3748\/wjg.14.4535","article-title":"Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention","volume":"14","author":"Feng","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"7","key":"10.1002\/14651858.CD005583.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-151-7-200910060-00014","article-title":"Redundant data in the meta-analysis on Helicobacter pylori eradication","volume":"151","author":"Ford","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"4-5","key":"10.1002\/14651858.CD005583.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bpg.2011.09.002","article-title":"Chemoprevention for gastric cancer","volume":"25","author":"Ford","year":"2011","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.302.6788.1302","article-title":"Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation","volume":"302","author":"Forman","year":"1991","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005583.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1136\/gut.43.2008.S33","article-title":"Helicobacter pylori: the gastric cancer problem","volume":"43 Suppl 1","author":"Forman","year":"1998","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD005583.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-151-2-200907210-00009","article-title":"Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?","volume":"151","author":"Fuccio","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005583.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0197-2456(98)00016-6","article-title":"Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data","volume":"19","author":"Gail","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","year":"2001","journal-title":"Gut"},{"issue":"7414","key":"10.1002\/14651858.CD005583.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005583.pub2-BIB74|cit74","first-page":"177","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","year":"1994","journal-title":"IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans"},{"issue":"11","key":"10.1002\/14651858.CD005583.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2006.00778.x","article-title":"Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival","volume":"101","author":"Lau","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","article-title":"The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention","volume":"62","author":"Lee","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/02841860600996462","article-title":"Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years","volume":"46","author":"Lello","year":"2007","journal-title":"Acta Oncologica"},{"issue":"9","key":"10.1002\/14651858.CD005583.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2003.034629","article-title":"Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2004","journal-title":"Gut"},{"key":"10.1002\/14651858.CD005583.pub2-BIB79|cit79","first-page":"S61","article-title":"Fifteen-year effects of Helicobacter pylori treatment on gastric cancer incidence and mortality among participants with different baseline gastric lesions and ages","volume":"177 (Suppl 11)","author":"Li","year":"2013","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jnci\/djs003","article-title":"Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality","volume":"104","author":"Ma","year":"2012","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"10.1002\/14651858.CD005583.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfil Koch's postulates for pyloric Campylobacter","volume":"142","author":"Marshall","year":"1985","journal-title":"Medical Journal of Australia"},{"issue":"11","key":"10.1002\/14651858.CD005583.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2005.072009","article-title":"Long term follow up of patients treated for Helicobacter pylori infection","volume":"54","author":"Mera","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1052-5157(18)30322-2","article-title":"Significance of Helicobacter pylori infection and gastric cancer: implications for screening","volume":"7","author":"Moayyedi","year":"1997","journal-title":"Gastrointestinal Endoscopy Clinics of North America"},{"issue":"16","key":"10.1002\/14651858.CD005583.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"The New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD005583.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"The New England Journal of Medicine"},{"issue":"9021","key":"10.1002\/14651858.CD005583.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","article-title":"Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials","volume":"348","author":"Parsonnet","year":"1996","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD005583.pub2-BIB87|cit87","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"12","key":"10.1002\/14651858.CD005583.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1111\/j.1572-0241.2001.05326.x","article-title":"Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection","volume":"96","author":"Ruiz","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB89|cit89","first-page":"50","article-title":"Present state of Japanese intervention trial of H. pylori","volume":"61","author":"Saito","year":"2003","journal-title":"Nihon Rinsho"},{"key":"10.1002\/14651858.CD005583.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2000.8550","article-title":"Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study","volume":"119","author":"Sung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005583.pub2-BIB92|cit92","series-title":"Gastroenterology","first-page":"A170. Abstract","article-title":"Does eradication of H. pylori prevent deterioration of gastric atrophy and intestinal metaplasia? A 5-year follow-up","author":"Sung","year":"2002"},{"key":"10.1002\/14651858.CD005583.pub2-BIB93|cit93","unstructured":"Forman D Delaney B Kuipers E Malthaner R Moayyedi P Gardener E Cochrane Upper GI and Pancreatic Diseases Group module http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clabout\/articles\/UPPERGI\/sect0-meta.html"},{"issue":"7","key":"10.1002\/14651858.CD005583.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2009.03.031","article-title":"Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms","volume":"7","author":"Vakil","year":"2009","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/jn.108.091389","article-title":"Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population","volume":"139","author":"Wang","year":"2009","journal-title":"Journal of Nutrition"},{"issue":"8336","key":"10.1002\/14651858.CD005583.pub2-BIB96|cit96","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD005583.pub2-BIB97|cit97","series-title":"Gastroenterology","first-page":"A588. Abstract","article-title":"Eradication of Helicobacter pylori infection significantly slows down the progression of precancerous lesions in high risk populations: a 5 year prospective randomized study","author":"Wong","year":"2002"},{"key":"10.1002\/14651858.CD005583.pub2-BIB98|cit98","series-title":"Journal of Gastroenterology and Hepatology","first-page":"5-6. Abstract U","article-title":"Eradication of Helicobacter pylori for prevention of gastric cancer","author":"Wong","year":"2012"},{"key":"10.1002\/14651858.CD005583.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ijc.10887","article-title":"Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus","volume":"103","author":"Wu","year":"2003","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/djh057","article-title":"Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia","volume":"96","author":"Ye","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00008469-200106000-00009","article-title":"An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity","volume":"10","author":"You","year":"2001","journal-title":"European Journal of Cancer Prevention"},{"issue":"14","key":"10.1002\/14651858.CD005583.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/djj264","article-title":"Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions","volume":"98","author":"You","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD005583.pub2-BIB103|cit103","first-page":"338","article-title":"A randomized multi-intervention trial to inhibit gastric cancer in Shandong (progress report)","volume":"25","author":"Zhang","year":"1998","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005583.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/ajcn\/84.4.912","article-title":"A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins","volume":"86","author":"Zhang","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3760\/cma.j.issn.0366-6999.20121090","article-title":"A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication","volume":"116","author":"Zhou","year":"2003","journal-title":"Chinese Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD005583.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1443-9573.2003.00104.x","article-title":"Five-year follow-up study after Helicobacter pylori eradication: Reinfection and peptic ulcer status","volume":"4","author":"Zhou","year":"2003","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD005583.pub2-BIB107|cit107","doi-asserted-by":"crossref","unstructured":"Zhou LY Sung JJ Lin SR Jin Z Ding SG Huang XB Changes of gastric mucosa histopathology after Helicobacterpylori eradication Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine] 2003 162 4","DOI":"10.1046\/j.1443-9573.2003.00104.x"},{"issue":"6","key":"10.1002\/14651858.CD005583.pub2-BIB108|cit108","first-page":"324","article-title":"Eight-year follow-up study on prevalence of gastric cancer and the histological changes of gastric mucosa after H.pylori eradication","volume":"25","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Digestion"},{"key":"10.1002\/14651858.CD005583.pub2-BIB109|cit109","unstructured":"Zhou LY Lin SR Ding SG Huang SB Guo CJ Zhang L Eight-year follow-up study on the morbidity of gastric cancer and the pathological changes of gastric mucosa after H.pylori eradication www.paper.edu.cn\/scholar\/downpaper\/zhouliya-3"},{"issue":"3","key":"10.1002\/14651858.CD005583.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1443-9573.2005.00204.x","article-title":"The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area","volume":"6","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD005583.pub2-BIB111|cit111","series-title":"Gastroenterology","first-page":"A233. Abstract","article-title":"Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in China","author":"Zhou","year":"2008"},{"key":"10.1002\/14651858.CD005583.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"g3174","DOI":"10.1136\/bmj.g3174","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials","volume":"348","author":"Ford","year":"2014","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005583.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005583.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:39:04Z","timestamp":1717990744000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005583.pub2"}},"subtitle":[],"editor":[{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":112,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005583.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005583.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2015,7,22]]}}}